Shenzhen Weiguang Biological Products Co.Ltd(002880)
Report on the use of previously raised funds
The company and its directors, supervisors and senior managers guarantee that the contents of the announcement are true, accurate and complete, and are liable for false records, misleading statements or major omissions in the announcement.
According to the provisions of the China Securities Regulatory Commission on the report on the use of previously raised funds (Zheng Jian FA FA Zi [2007] No. 500), Shenzhen Weiguang Biological Products Co.Ltd(002880) (hereinafter referred to as “the company” or “the company”) will report the use of previously raised funds as of December 31, 2020 as follows:
1、 Previous fund raising
(I) the amount of funds raised last time and the time of receipt of funds
According to the reply on approving Shenzhen Weiguang Biological Products Co.Ltd(002880) initial public offering of shares (zjxk [2017] No. 760) issued by China Securities Regulatory Commission on May 19, 2017, the company was approved to publicly issue 27 million ordinary shares, raising a total of 677.97 million yuan, deducting underwriting and recommendation fees After the issuance registration fee and other transaction expenses totaled 55.013 million yuan, the net raised funds totaled 622957 million yuan. The above funds were in place on June 8, 2017, which was verified by Ruihua certified public accountants and issued the capital verification report “Ruihua Yan Zi [2017] No. 48230006”.
(II) deposit of the previously raised funds in the special account
In order to standardize the management and use of raised funds and protect the interests of investors, the company has formulated the Shenzhen Weiguang Biological Products Co.Ltd(002880) raised funds management system (hereinafter referred to as the “raised funds management system”) in accordance with the relevant provisions and requirements of the stock listing rules of Shenzhen Stock Exchange and the guidelines for the standardized operation of listed companies of Shenzhen Stock Exchange and in combination with the actual situation of the company.
According to the management system of raised funds, the company implements special accounts for the raised funds. In July 2017, the company set up four special accounts for the raised funds in Bank Of China Limited(601988) Shenzhen Longhua sub branch, Agricultural Bank Of China Limited(601288) Shenzhen Branch, China Citic Bank Corporation Limited(601998) Shenzhen Branch, Ping An Bank Co.Ltd(000001) Shenzhen branch respectively, and cooperated with the deposit bank The sponsor Ping An Securities Co., Ltd. (hereinafter referred to as “Ping An Securities”) has signed the tripartite supervision agreement on raised funds, and the main terms of the agreement are not significantly different from the tripartite supervision agreement (model) on raised funds of Shenzhen Stock Exchange.
As of December 31, 2020, the company signed the tripartite supervision agreement on raised funds, and the storage of raised funds in the special account is as follows:
The balance of the bank account number of the deposit bank of the raised funds (10000 yuan)
1 specific immunoglobulin and coagulation 2406325 Bank Of China Limited(601988) Co., Ltd. 7679690303192637.31 factor product industrialization project Department Shenzhen Longhua sub branch
2 plasma collection station reconstruction and expansion project 523573 China Agricultural Bank Of China Limited(601288) Co., Ltd. has 410319004 Dong Yi Ri Sheng Home Decoration Group Co.Ltd(002713) 22.81 Shenzhen Branch
3. Construction of engineering technology research and development center 1449672 China Citic Bank Corporation Limited(601998) Co., Ltd. 8110 Jiangsu Yangdian Science & Technology Co.Ltd(301012) 7 Wuhan Fingu Electronic Technology Co.Ltd(002194) 81206.60 set up project Department Shenzhen Branch
4 repayment of bank loan 1850000 Ping An Bank Co.Ltd(000001) Co., Ltd. 15 China High-Speed Railway Technology Co.Ltd(000008) 58802290.02 Shenzhen Branch
Total 6229570384674
On July 21, 2017, the 10th meeting of the second board of directors of the company deliberated and approved the proposal on using the raised funds to increase the capital of wholly-owned subsidiaries. In order to implement the reconstruction and expansion project of plasma collection station invested by the raised funds, the raised funds of 523573 million yuan were used to invest in Debao Guangming plasma collection Co., Ltd. (hereinafter referred to as “Debao”) Tianyang Guangming apheresis plasma Co., Ltd. (hereinafter referred to as “Tianyang”), Pingguo Guangming apheresis plasma Co., Ltd. (hereinafter referred to as “Pingguo”), Long’an Guangming apheresis plasma Co., Ltd. (hereinafter referred to as “Long’an”), Zhongshan Guangming apheresis plasma Co., Ltd. (hereinafter referred to as “Zhongshan”) Luoding Weiguang apheresis plasma Co., Ltd. (hereinafter referred to as “Luoding”) increased its capital and established a special account for raised funds in Agricultural Bank Of China Limited(601288) Shenzhen Guangming sub branch (hereinafter referred to as “Guangming sub branch of Agricultural Bank of China”). The company has signed the four party supervision agreement on raised funds with Debao, Tianyang, Pingguo, Long’an, Zhongshan, Luoding, Guangming branch of Agricultural Bank of China and Ping An Securities, and the main terms of the agreement are not significantly different from the three party supervision agreement (model) on raised funds of Shenzhen Stock Exchange.
As of December 31, 2020, the company signed the four party supervision agreement on raised funds, and the storage of raised funds in the special account is as follows:
No. name of main project to be implemented capital increase amount (ten thousand yuan of fund balance at the end of the period in the bank account of the bank where the raised funds are opened) bank amount (ten thousand yuan)
1 Pingguo business housing reconstruction and expansion 120000 Guangming branch of Agricultural Bank of China 410319004 Ife Elevators Co.Ltd(002774) 45.31
2. Reconstruction and expansion of Long’an single plasma collection station 105017 Guangming sub branch of Agricultural Bank of China 410319004 Chengdu Kanghong Pharmaceutical Group Co.Ltd(002773) 6108.00
3 Tianyang plasma collection station newly built 996.08 Guangming sub branch of Agricultural Bank of China 410319004 Shenzhen Qixin Group Co.Ltd(002781) 91.52
4 Debao reconstruction and expansion 717.48 Guangming sub branch of Agricultural Bank of China 410319004 Xiamen Wanli Stone Stock Co.Ltd(002785) 00.04
5 Zhongshan pulp mining business building 972.00 Guangming sub branch of Agricultural Bank of China 410319004 Beijing Transtrue Technology Inc(002771) 00.54
6 Luoding decoration and reconstruction 300.00 Guangming sub branch of Agricultural Bank of China 410319004 Tianshui Zhongxing Bio-Technology Co.Ltd(002772) 80.002
Total 523573 115.41
The company implements strict examination and approval procedures for the use of raised funds to ensure that the special funds are used for special purposes.
As of December 31, 2020, the fund-raising supervision agreements have been effectively implemented.
2、 Actual use of the previously raised funds
As of December 31, 2020, the use of raised funds was in line with the company’s commitment to the use of raised funds. See Schedule 1 comparison table of the use of raised funds in this report for the table of the use of raised funds.
3、 Changes in raised funds
At the 32nd meeting of the second board of directors on July 30, 2020 and the first extraordinary general meeting of shareholders in 2020 on August 27, 2020, the proposal on changing the use of part of the raised funds was deliberated and approved. The Zhongshan plasma station project in the company’s fund-raising project “reconstruction and expansion project of plasma collection station” raised 9.72 million yuan, and the raised funds have been used 2.5579 million yuan, As of June 30, 2020, the balance of the fund-raising account of the project was 7.2354 million yuan (including interest). As No. 31, Guishi South Road, Zhongshan town, Zhongshan County, where the Zhongshan pulp station project is located, is requisitioned by the government, the company plans to change the implementation of the original fund-raising and investment plan, relocate the original Zhongshan pulp station to the East-West side of Chengshi Village section of fast Ring Road, Zhongshan Town, Zhongshan County, rebuild, expand the business building area of the pulp station, introduce advanced pulp collection and testing equipment, and increase sewage treatment system. The company changed the remaining raised funds of 7.2354 million yuan (including interest) of Zhongshan plasma station project in the raised investment project “reconstruction and expansion project of single plasma collection station” to the construction investment of new Zhongshan plasma station.
4、 Advance investment and replacement of investment projects with raised funds
After deliberation by the second board of directors of the company on July 21, 2017, it was agreed to use the raised funds of 186467900 yuan to replace the self raised funds of 186467900 yuan invested by the company in the investment projects with raised funds in advance. The board of supervisors and independent directors of the company also expressed clear consent. On July 21, 2017, Ping An Securities, the sponsor, announced the verification opinions on Shenzhen Weiguang Biological Products Co.Ltd(002880) using the raised funds to replace the self raised funds invested in the raised investment projects in advance, and had no objection to the company’s using the raised funds to replace the self raised funds invested in the raised investment projects in advance. Ruihua Certified Public Accountants (special general partnership) issued an assurance report on the investment projects invested with raised funds in advance with self raised funds (ruihuahe [2017] No. 48230015). The details are as follows:
No. project name commitment raised funds investment funds self raised funds pre investment replacement amount (10000 yuan) (10000 yuan) amount (10000 yuan)
1. Industrialization project of specific immunoglobulins and coagulation factors 2406325745162745162 products
Reconstruction and expansion project of 2 plasma collection station 523573185833185833
3. Construction project of engineering technology research and development center 1449672933684933684
Total 437957018646791864679
5、 Use of idle raised funds
The 12th meeting of the second board of directors was held on September 7, 2017, which considered and adopted the proposal on using some idle raised funds to supplement working capital, and agreed to use 80 million yuan of idle raised funds to supplement working capital, with a service life of no more than 12 months; On August 7, 2018, the company has returned all the idle raised funds of RMB 80 million temporarily replenishing working capital to the special account for raised funds.
On August 16, 2018, the 16th meeting of the second board of directors deliberated and approved the proposal on continuing to use some idle raised funds to temporarily supplement working capital, and agreed that the company would use 100 million yuan of idle raised funds to temporarily supplement working capital, and the service life would not exceed 12 months from the date of deliberation and adoption by the board of directors. On August 14, 2019, the company has returned all the idle raised funds of RMB 100 million temporarily supplemented with working capital to the special account for raised funds.
On August 29, 2019, the 25th meeting of the second board of directors and the 17th meeting of the second board of supervisors respectively deliberated and approved the proposal on continuing to use some idle raised funds to supplement working capital, and agreed that the company would use 80 million yuan of idle raised funds to supplement working capital temporarily, and the service life would not exceed 12 months from the date of deliberation and approval by the board of directors. On July 17, 2020, the company has returned all the idle raised funds of 80 million yuan temporarily supplemented with working capital to the special account for raised funds. On July 30, 2020, the 32nd meeting of the second board of directors and the 22nd Meeting of the second board of supervisors respectively considered and approved the proposal on continuing to use some idle raised funds to temporarily supplement working capital, and agreed that the company would use 60 million yuan of idle raised funds to temporarily supplement working capital, The service life shall not exceed 12 months from the date of deliberation and approval by the board of directors. 6、 Unused fund balance of the previously raised funds
As of December 31, 2020, the accumulated use of the company’s fund-raising projects was 5268837 million yuan, the accumulated account interest (deducting handling fees) of the raised funds was 3.5482 million yuan, and the balance of the raised funds was 3962 million yuan
